Brown Advisory’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Buy |
15,313
+1,837
| +14% | +$128K | ﹤0.01% | 796 |
|
|
2025
Q1 | $990K | Sell |
13,476
-885
| -6% | -$65K | ﹤0.01% | 792 |
|
|
2024
Q4 | $941K | Sell |
14,361
-139
| -1% | -$9.11K | ﹤0.01% | 816 |
|
|
2024
Q3 | $1.13M | Buy |
14,500
+357
| +3% | +$27.8K | ﹤0.01% | 763 |
|
|
2024
Q2 | $1.1M | Buy |
14,143
+4,950
| +54% | +$386K | ﹤0.01% | 750 |
|
|
2024
Q1 | $623K | Buy |
9,193
+382
| +4% | +$25.9K | ﹤0.01% | 884 |
|
|
2023
Q4 | $593K | Sell |
8,811
-902
| -9% | -$60.8K | ﹤0.01% | 891 |
|
|
2023
Q3 | $658K | Buy |
9,713
+999
| +11% | +$67.7K | ﹤0.01% | 842 |
|
|
2023
Q2 | $624K | Buy |
8,714
+2,181
| +33% | +$156K | ﹤0.01% | 852 |
|
|
2023
Q1 | $453K | Buy |
6,533
+1,204
| +23% | +$83.6K | ﹤0.01% | 943 |
|
|
2022
Q4 | $361K | Sell |
5,329
-354
| -6% | -$24K | ﹤0.01% | 984 |
|
|
2022
Q3 | $312K | Buy |
5,683
+113
| +2% | +$6.2K | ﹤0.01% | 953 |
|
|
2022
Q2 | $368K | Sell |
5,570
-836
| -13% | -$55.2K | ﹤0.01% | 911 |
|
|
2022
Q1 | $425K | Buy |
+6,406
| New | +$425K | ﹤0.01% | 897 |
|
|
2021
Q3 | – | Sell |
-6,339
| Closed | -$380K | – | 1107 |
|
|
2021
Q2 | $380K | Buy |
+6,339
| New | +$380K | ﹤0.01% | 897 |
|
|
2018
Q3 | – | Sell |
-7,127
| Closed | -$250K | – | 1333 |
|
|
2018
Q2 | $250K | Buy |
7,127
+1,238
| +21% | +$43.4K | ﹤0.01% | 1160 |
|
|
2018
Q1 | $206K | Sell |
5,889
-4,052
| -41% | -$142K | ﹤0.01% | 1101 |
|
|
2017
Q4 | $345K | Buy |
+9,941
| New | +$345K | ﹤0.01% | 992 |
|